Profile of:

Laure Gossec


Laure Gossec, MD, PhD, is Professor of Rheumatology in Sorbonne Université and Pitié-Salpêtrière Hospital, Paris, France. Laure Gossec has a half-time clinical position where she mainly sees patients with inflammatory arthritis, and a half-time teaching and research position. Her main research interests within outcomes research and epidemiological research, are patient-reported outcomes and quality of life, as well as e-health and big data, in psoriatic arthritis, spondyloarthritis and rheumatoid arthritis. Professor Gossec is a Past-Chair of the Epidemiology standing committee of EULAR. She is one of the editors of the journal Joint Bone Spine. Professor Gossec has authored more than 450 peer-reviewed manuscripts.

Full name: Laure Gossec

Current country: France

Membership level: Full

Type of membership: Member

Number of publications: 25

Development and Validation of a Self-Administered Questionnaire Measuring Essential Knowledge in Patients With Axial Spondyloarthritis (2023)
https://pubmed.ncbi.nlm.nih.gov/35840152/

Evaluation of the agreement between the ACR 1990 fibromyalgia tender points and an enthesitis score in patients with axial spondyloarthritis. (2022)
https://pubmed.ncbi.nlm.nih.gov/36573318/

Challenges in interpreting sacroiliac magnetic resonance imaging for the diagnosis of axial spondyloarthritis. (2022)
https://pubmed.ncbi.nlm.nih.gov/36184037/

Predictors of response to secukinumab in patients with psoriatic arthritis and axial manifestations: a post-hoc analysis of the MAXIMISE trial (2022)
https://pubmed.ncbi.nlm.nih.gov/35850974/

Spine abnormalities associated with bone edema on sacroiliac joints MRI in patients with non-inflammatory chronic back pain (2022)
https://pubmed.ncbi.nlm.nih.gov/35777553/

Defining and managing flares in axial spondyloarthritis (2022)
https://pubmed.ncbi.nlm.nih.gov/35699318/

Impact of Axial Spondyloarthritis on Quality of Life: Results From the European Map of Axial Spondyloarthritis (EMAS) Study in France (2022)
https://pubmed.ncbi.nlm.nih.gov/35569828/

Efficacy of a nurse-led patient education intervention in promoting safety skills of patients with inflammatory arthritis treated with biologics: a multicentre randomised clinical trial (2022)
https://pubmed.ncbi.nlm.nih.gov/35296528/

Prevalence and consequences of psoriasis in recent axial spondyloarthritis: an analysis of the DESIR cohort over 6 years (2022)
https://pubmed.ncbi.nlm.nih.gov/35091462/

2022 French Society for Rheumatology (SFR) recommendations on the everyday management of patients with spondyloarthritis, including psoriatic arthritis (2022)
https://pubmed.ncbi.nlm.nih.gov/35038574/

Fluctuation of pain is frequent in rheumatoid arthritis and axial spondyloarthritis: A 12 weeks prospective study of 165 patients (2022)
https://pubmed.ncbi.nlm.nih.gov/34740728/

Fluctuation of pain is frequent in rheumatoid arthritis and axial spondyloarthritis: A 12 weeks prospective study of 165 patients (2021)
https://pubmed.ncbi.nlm.nih.gov/34740728/

Influence of perceived barriers and facilitators for physical activity on physical activity levels in patients with rheumatoid arthritis or spondyloarthritis: a cross-sectional study of 150 patients (2021)
https://pubmed.ncbi.nlm.nih.gov/34717606/

Development of an environmental contextual factor item set relevant to global functioning and health in patients with axial Spondyloarthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/34534275/

Exploring remission concept in axial spondyloarthritis through the perception of rheumatologists using vignettes and priority ratings (2021)
https://pubmed.ncbi.nlm.nih.gov/34528070/

Patients’ safety skills assessment with biologics and JAK inhibitors: Update of the BioSecure questionnaire (2021)
https://pubmed.ncbi.nlm.nih.gov/33992790/

Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial (2021)
https://pubmed.ncbi.nlm.nih.gov/33958325/

SARS-CoV-2 outbreak in immune-mediated inflammatory diseases: the Euro-COVIMID multicentre cross-sectional stud (2021)
https://pubmed.ncbi.nlm.nih.gov/33942031/

The adherence questionnaires in chronic inflammatory rheumatic diseases and their psychometric properties: A systematic literature review (2021)
https://pubmed.ncbi.nlm.nih.gov/33578034/

To apply the recent EULAR recommendations, more knowledge on adherence patterns to medication and to physical activity is needed (2021)
https://pubmed.ncbi.nlm.nih.gov/33484861/

Gender differences in patient journey to diagnosis and disease outcomes: results from the European Map of Axial Spondyloarthritis (EMAS) (2021)
https://pubmed.ncbi.nlm.nih.gov/33464431/

Secukinumab in patients with psoriatic arthritis and axial manifestations: results from the double-blind, randomised, phase 3 MAXIMISE trial (2021)
https://pubmed.ncbi.nlm.nih.gov/33334727/

Secukinumab Provides Sustained Reduction in Fatigue in Patients with Ankylosing Spondylitis: Long-term Results of Two Phase III Randomized Controlled Trials (2021)
https://pubmed.ncbi.nlm.nih.gov/33227175/

Evaluation of the impact of a nurse-led program of patient self-assessment and self-management in axial spondyloarthritis: results of a prospective, multicentre, randomized, controlled trial (COMEDSPA) (2021)
https://pubmed.ncbi.nlm.nih.gov/33063096/

Prediction of Work Impact in Axial Spondyloarthritis by the Work Instability Scale: A Prospective Cohort Study of 101 Patients (2021)
https://pubmed.ncbi.nlm.nih.gov/32934129/